Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 3361 of 6372
-
Stem cells tested for tough Crohn's fistulas – but trial stopped early
Disease control Stopped earlyRestorative proctocolectomy with ileal pouch anal anastomosis (IPAA) is the procedure of choice for patients with ulcerative colitis, familial adenomatous polyposis, and select patients with Crohn's disease due to overall low patient morbidity and good quality of life. However, s…
Phase 1/2 • Sponsor: Anthony Lembo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Ultrasound may spare lung transplant patients from painful biopsies
Diagnosis Recruiting nowThis study is being done to study a safe and non-invasive way to diagnose lung rejection and infection.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Brain zaps may quiet epileptic spikes and boost language in kids
Knowledge-focused CompletedBenign epilepsy with centrotemporal spikes (BECTS) is the most common pediatric epilepsy syndrome. Affected children typically have a mild seizure disorder, but yet have moderate difficulties with language, learning and attention that impact quality of life more than the seizures…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:09 UTC
-
Can a common drug stop Chemo's nerve pain?
Prevention PausedIt is a phase II trial, randomized, parallel, double blind, multicenter, comparing riluzole versus placebo. The trial population is composed of patients ≥18 years old that have developed stage II/III colorectal cancer and are eligible for Simplified FOLFOX4 (6-12 cycles) adjuvan…
Phase 2 • Sponsor: UNICANCER • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
New rectal cancer device tested in elderly patients
Disease control PausedWithin our institution, the principal investigator have acquired expertise in endorectal brachytherapy, a localized treatment for colorectal cancer. Until now a modality which uses an endorectal applicator has been used, which has certain limitations. In the context of this study…
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo targets Hard-to-Treat lung cancer
Disease control OngoingThis phase I/Ib trial studies the side effects and best dose of CB-839 HCl when given together with sapanisertib in treating patients with non-small cell lung cancer that has spread to other places in the body (advanced). CB-839 HCl and sapanisertib may stop the growth of tumor c…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Lung cancer drug combo trial halted early
Disease control Stopped earlyPrimary Objective: * Safety run-in part: to assess the tolerability and to determine the recommended doses of tusamitamab ravtansine in combination with pembrolizumab and tusamitamab ravtansine in combination with pembrolizumab and platinum-based chemotherapy with or without pem…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Pain monitor slashes morphine use in Kids' spine surgery
Symptom relief CompletedAnaesthesia is often performed using a balanced technique by administering both opioids and anaesthetics agents. Intraoperative opioid administration is still relying on simple parameters such as heart rate and blood pressure variations. However, many studies in both adults and c…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Cheaper, Needle-Free option for Post-Surgery nausea in children put to the test
Symptom relief CompletedThe hypothesis being tested in this study is that perioperative oral administration of dexamethasone, when compared to intravenous (IV) administration, offers a similar reduction in postoperative nausea and vomiting (PONV), and reduction in postoperative pain in pediatric patient…
Phase 4 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Can donor plasma fix clotting issues in sepsis? new study investigates
Disease control CompletedNo randomized controlled trial (RCT) has investigated the effect of prophylactic fresh frozen plasma (FFP) transfusion in septic or critically ill patients with coagulation abnormalities. The last Surviving Sepsis Campaign therefore suggests with a very low quality of evidence "a…
Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hepatitis b pill shows promise in early human trial
Disease control CompletedThe goal of this clinical trial is to learn if ALG-000184 is safe, well-tolerated, and works to treat chronic hepatitis B virus (HBV) infection. The main questions it aims to answer are: Is ALG-000184 safe and well-tolerated when given alone or with entecavir (a standard HBV tre…
Phase 1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a common cholesterol drug tame inflammatory bowel disease?
Disease control Stopped early* Evaluation of the microbiota modulation away from inflammation associated microbiota profile Bacteroides2 (Bact2) * Evaluation of the effect of microbiota modulation on disease activity in ulcerative colitis and Crohn's disease patients.
Phase 2/3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Stage fright to social success: theatre program shows promise for adults with autism
Symptom relief CompletedSENSE Theatre®, combines several well-documented, effective behavioral strategies, such as the inclusion of trained peer models, theatre play techniques involving predictable (i.e., scripted) and flexible (improvised) role-play, and repeated performance of newly learned skills re…
Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New tests aim to spot bone marrow graft failure early
Knowledge-focused Recruiting nowThe purpose of this study is to find new tests that could help determine if the newly infused bone marrow cells are growing well after bone marrow transplantation or if new bone marrow cells are needed. The Investigator will use FLT imaging, an investigational imaging test, and c…
Phase 1 • Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Blood filtering procedure tested as new weapon against deadly sepsis
Disease control CompletedThe incidence of sepsis (severe infection) has increased over the last four decades. Severe sepsis and septic shock are among the leading causes of death for patients admitted to critical care units with mortality ranging from 20-70% depending on totality of organ dysfunction. Ou…
Phase 1 • Sponsor: Alberta Health Services, Calgary • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New program boosts treatment adherence for Dual-Diagnosis patients
Disease control CompletedThis trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other…
Sponsor: Butler Hospital • Aim: Disease control
Last updated Sep 10, 2026 14:00 UTC
-
New nanoparticle chemo shows promise in early trial for tough cancers
Disease control CompletedSNB-101 is a novel nano-particle formulation of SN-38, the active metabolite of irinotecan(CPT-11). Study SNB101P01 is a multicenter, open-label, dose escalation, phase 1 study of SNB 101 with its active ingredient SN-38, in participants with advanced solid tumors. Dose escalatio…
Phase 1 • Sponsor: SN BioScience • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Breaking the spray cycle: new study tackles nasal decongestant addiction
Disease control CompletedRhinitis medicamentosa (RM) is a form of non-allergic medication-induced rhinitis characterised by nasal congestion. This nasal congestion is the result of the overuse of intranasal decongestants which leads to rebound congestion when the medication wears off. This prompts the us…
Phase 4 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Mayo clinic tests which brain stimulation frequency stops seizures best
Knowledge-focused Recruiting nowA primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Personalized tamoxifen dosing: can a PET scan show the way?
Knowledge-focused Recruiting nowDespite broad advancements in endocrine therapy for ERα+ breast cancer, resistance ultimately develops. A common driver of resistance are known ESR1 mutations that lead to constitutively active receptor signaling and transcriptional regulation that is always "turned on" despite t…
Early phase 1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC